BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8677872)

  • 1. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.
    Gharavi AG; Lipkowitz MS; Diamond JA; Jhang JS; Phillips RA
    Am J Cardiol; 1996 Jun; 77(15):1315-9. PubMed ID: 8677872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.
    Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G
    J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus.
    Estacio RO; Jeffers BW; Havranek EP; Krick D; Raynolds M; Schrier RW
    Am J Hypertens; 1999 Jun; 12(6):637-42. PubMed ID: 10371375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.
    Perticone F; Ceravolo R; Cosco C; Trapasso M; Zingone A; Malatesta P; Perrotti N; Tramontano D; Mattioli PL
    J Am Coll Cardiol; 1997 Feb; 29(2):365-9. PubMed ID: 9014990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes.
    Kasikcioglu E; Kayserilioglu A; Ciloglu F; Akhan H; Oflaz H; Yildiz S; Peker I
    Heart Vessels; 2004 Nov; 19(6):287-93. PubMed ID: 15799176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.
    Celentano A; Mancini FP; Crivaro M; Palmieri V; Ferrara LA; De Stefano V; Di Minno G; de Simone G
    Am J Cardiol; 1999 Apr; 83(8):1196-200. PubMed ID: 10215283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population.
    Jalil JE; Piddo AM; Cordova S; Chamorro G; Braun S; Jalil R; Vega J; Jadue'P L; Lavandero S; Lastra P
    Am J Hypertens; 1999 Jul; 12(7):697-704. PubMed ID: 10411367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele.
    Prasad N; O'Kane KP; Johnstone HA; Wheeldon NM; McMahon AD; Webb DJ; MacDonald TM
    QJM; 1994 Nov; 87(11):659-62. PubMed ID: 7820539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACE gene polymorphism correlation (I/D) with the ventricular function in patients with ischemic and idiopathic dilated cardiomyopathy].
    Avila-Vanzzini N; Espínola-Zavaleta N; Masso-Rojas F; Varela-López E; Casanova-Garcés JM; Kury-Alfaro J; Herrera-Bello H
    Rev Invest Clin; 2006; 58(1):39-46. PubMed ID: 16789598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
    Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
    Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
    Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
    Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.
    Iwai N; Ohmichi N; Nakamura Y; Kinoshita M
    Circulation; 1994 Dec; 90(6):2622-8. PubMed ID: 7994801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
    Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
    Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men.
    López-Contreras J; Blanco-Vaca F; Borrás X; Carreras F; Pons-Lladó G; Gallego F; Solé MJ; Cirera S; Benet MT; Negredo E; Roca-Cusachs A
    J Hum Hypertens; 2000 May; 14(5):327-31. PubMed ID: 10822320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.